Latest filing published 05 Apr 2021 for Intercept Pharmaceuticals, INC., €948.
Filing timeline
BuySaleInsider track record
Christian Weyer: trading record in brief
Filings by Christian Weyer span 3 companies, the busiest being Intercept Pharmaceuticals, Inc., Amylin Pharmaceuticals Inc and Fate Therapeutics Inc. We count 70 filings; the first trade dates from 19 November 2010 and the latest from 1 April 2021.
Sales make up the whole of the open-market record (17 sales, €1.5M). Other entries cover 35 share grants and 11 option exercises.
Most recently, on 5 April 2021, the filings show a share grant worth €948 in Intercept Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christian Weyer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 46 shares@ US$24.280.0% of flowCommon StockSEC:0001104659-21-046702:0
- 357 shares@ US$21.660.3% of flowCommon StockSEC:0001104659-21-030900:0
- 12,600 shares0Common StockSEC:0001104659-21-007783:0
- 779 shares@ US$24.700.7% of flowCommon StockSEC:0001104659-21-001126:0
- 54 shares@ US$24.700.1% of flowCommon StockSEC:0001104659-21-001126:1
- 357 shares@ US$37.275.2% of flowCommon StockSEC:0001104659-20-130699:0
- 46 shares@ US$42.080.8% of flowCommon StockSEC:0001104659-20-112320:0
- 357 shares@ US$48.815.1% of flowCommon StockSEC:0001104659-20-100946:0
- 46 shares@ US$46.520.1% of flowCommon StockSEC:0001104659-20-081442:0
- 357 shares@ US$74.431.4% of flowCommon StockSEC:0001104659-20-067902:0
- 181 shares@ US$85.950.8% of flowCommon StockSEC:0001104659-20-053658:0
- 46 shares@ US$58.400.1% of flowCommon StockSEC:0001104659-20-043290:0
- 357 shares@ US$85.391.6% of flowCommon StockSEC:0001104659-20-027330:0
- 113 shares@ US$87.620.5% of flowCommon StockSEC:0001104659-20-027330:1
- 4,800 shares0Common StockSEC:0001104659-20-007260:0
- 723 shares@ US$94.042.9% of flowCommon StockSEC:0001104659-20-007260:1
- 364 shares@ US$123.921.9% of flowCommon StockSEC:0001104659-20-001087:0
- 54 shares@ US$123.920.3% of flowCommon StockSEC:0001104659-20-001087:1
- 416 shares@ US$59.121.1% of flowCommon StockSEC:0001104659-19-076864:0
- 54 shares@ US$58.740.1% of flowCommon StockSEC:0001104659-19-076864:1
- 1,581 shares@ US$123.248.4% of flowCommon StockSEC:0001104659-19-076864:2
- 875 shares@ US$59.122.2% of flowCommon StockSEC:0001104659-19-069103:0
- 52 shares@ US$58.740.1% of flowCommon StockSEC:0001104659-19-069103:1
- 1,040 shares@ US$101.654.6% of flowCommon StockSEC:0001104659-19-069103:2
- 357 shares@ US$109.161.7% of flowCommon StockSEC:0001104659-19-069103:3
25 of 67 declarations
